SEC Info - Seattle Genetics Inc/WA - ‘SC TO-C’ on 1/31/18 re: Cascadian Therapeutics, Inc.

SEC Info℠

Home

Help

Please Sign In

Seattle Genetics Inc/WA – ‘SC TO-C’ on 1/31/18 re: Cascadian Therapeutics, Inc.

On: Wednesday, 1/31/18, at 6:45am ET · Accession #: 1193125-18-26317 · File #: 5-84961

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 1/31/18  Seattle Genetics Inc/WA           SC TO-C                4:758K Cascadian Therapeutics, Inc.      Donnelley … Solutions/FA

Tender-Offer Statement – Preliminary Communication — Sch. TO
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC TO-C     8-K                                                 HTML     35K 
 2: EX-2.1      Plan of Acquisition, Reorganization, Arrangement,   HTML    394K 
                          Liquidation or Succession                              
 3: EX-10.1     Material Contract                                   HTML    120K 
 4: EX-99.1     Miscellaneous Exhibit                               HTML     24K

Filing Submission 0001193125-18-026317 – SGML Text

Original SGML Text submitted by:	Donnelley Financial Solutions/FA (as Filing Agent)

⇓Show all <DOCUMENT> <TEXT> elements below – 758K ↑Top ↓Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20180131-064600	 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20180131-064600	 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20180131-064509	 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0001193125-18-026317
<TYPE>				SC TO-C
<PUBLIC-DOCUMENT-COUNT>		6
<FILING-DATE>			20180131
<DATE-OF-FILING-DATE-CHANGE>	20180131

<SUBJECT-COMPANY>
<COMPANY-DATA>
<CONFORMED-NAME>		Cascadian Therapeutics, Inc.
<CIK>				0001412067
<ASSIGNED-SIC>			8731
<IRS-NUMBER>			260868560  ⇒ 26-0868560 or 260-86-8560
<STATE-OF-INCORPORATION>	DE
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			SC TO-C
<ACT>				34
<FILE-NUMBER>			005-84961
<FILM-NUMBER>			18560944
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			3101 WESTERN AVE.
<STREET2>			SUITE 600
<CITY>				SEATTLE
<STATE>				WA
<ZIP>				98121
<PHONE>				(206) 801-2100
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			3101 WESTERN AVE.
<STREET2>			SUITE 600
<CITY>				SEATTLE
<STATE>				WA
<ZIP>				98121
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		Oncothyreon Inc.
<DATE-CHANGED>			20070927
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		Biomira CORP
<DATE-CHANGED>			20070911
</FORMER-COMPANY>
</SUBJECT-COMPANY>

<FILED-BY>
<COMPANY-DATA>
<CONFORMED-NAME>		SEATTLE GENETICS INC /WA
<CIK>				0001060736
<ASSIGNED-SIC>			2836
<IRS-NUMBER>			911874389  ⇒ 91-1874389
<STATE-OF-INCORPORATION>	DE
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			SC TO-C
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			21823 30TH DRIVE SE
<STREET2>			SUITE
<CITY>				BOTHELL
<STATE>				WA
<ZIP>				98021
<PHONE>				4255274000
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			21823 30TH DRIVE SE
<STREET2>			SUITE
<CITY>				BOTHELL
<STATE>				WA
<ZIP>				98021
</MAIL-ADDRESS>
</FILED-BY>

<DOCUMENT>
<TYPE>		SC TO-C
<SEQUENCE>	1
<FILENAME>	d519414d8k.htm
<DESCRIPTION>	8-K
<TEXT>
<HTML>
       Show <HTML>: 334 lines (widest: 249 characters) - 41K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-2.1
<SEQUENCE>	2
<FILENAME>	d519414dex21.htm
<DESCRIPTION>	EX-2.1
<TEXT>
<HTML>
       Show <HTML>: 3,832 lines (widest: 254 characters) - 524K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10.1
<SEQUENCE>	3
<FILENAME>	d519414dex101.htm
<DESCRIPTION>	EX-10.1
<TEXT>
<HTML>
       Show <HTML>: 1,174 lines (widest: 251 characters) - 147K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-99.1
<SEQUENCE>	4
<FILENAME>	d519414dex991.htm
<DESCRIPTION>	EX-99.1
<TEXT>
<HTML>
       Show <HTML>: 168 lines (widest: 249 characters) - 26K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	5  ⇐ Not a Document/Exhibit
<FILENAME>	g519414untitled.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 151 lines (Unix-to-Unix encoding) - 9K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	6  ⇐ Not a Document/Exhibit
<FILENAME>	g519414untitleda.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 179 lines (Unix-to-Unix encoding) - 11K bytes  
</TEXT>
</DOCUMENT>

</SUBMISSION>

↑Top

Filing Submission 0001193125-18-026317 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Seattle Genetics Inc/WA – ‘SC TO-C’ on 1/31/18 re: Cascadian Therapeutics, Inc.

On: Wednesday, 1/31/18, at 6:45am ET · Accession #: 1193125-18-26317 · File #: 5-84961

Previous ‘SC TO-C’: None · Next: ‘SC TO-C’ on 1/31/18 · Latest: ‘SC TO-C’ on 2/7/18

Tender-Offer Statement – Preliminary Communication — Sch. TOFiling Table of Contents

Tender-Offer Statement – Preliminary Communication — Sch. TO
Filing Table of Contents